Alejandro Lara-García

Dr. Alejandro Lara-García

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2025 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
ALAlejandro Lara-García
Alejandro Lara-García
AJAlfonso Jurado-Roman
Alfonso Jurado-Roman
DMDaniel Tébar Márquez
Daniel Tébar Márquez
AGAriana Gonzálvez García
Ariana Gonzálvez García
SVSantiago Jiménez Valero
Santiago Jiménez Valero
RMRaúl Moreno
Raúl Moreno

8 May 2024 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
ALAlejandro Lara-García
Alejandro Lara-García
LGLucía Fernández Gassó
Lucía Fernández Gassó
EDEsther Pérez David
Esther Pérez David

7 March 2026 in REC: CardioClinics
Verified
Journal Article
Open access
ALAlejandro Lara-García
Alejandro Lara-García
CECarlos Escobar-Cervantes
Carlos Escobar-Cervantes
ARAdriana Rodríguez-Chaverri
Adriana Rodríguez-Chaverri
SRSandra Rosillo
Sandra Rosillo
JMJosé Luis Merino-Llorens
José Luis Merino-Llorens
RMRaúl Moreno
Raúl Moreno

18 February 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
LCLucía Canales-Muñoz
Lucía Canales-Muñoz
CUClara Ugueto-Rodrigo
Clara Ugueto-Rodrigo
CRCarlos Rodríguez-Carneiro
Carlos Rodríguez-Carneiro
ALAlejandro Lara-García
Alejandro Lara-García
LDLeonel Diaz-González
Leonel Diaz-González
RMRaúl Moreno
Raúl Moreno
Background: Myocardial calcification is a rare complication, typically associated with chronic myocardial injury or severe metabolic disturbances. Rapid development in the setting of cytokine release syndrome (CRS) and sepsis is exceptional and, to our knowledge, has not been previously reported. Case summary: We describe a 44-year-old man with acute myeloid leukaemia who developed CRS and subsequent septic shock, requiring high-dose vasopressor support and continuous renal replacement therapy. On day 70 of hospitalization, a computed tomography scan revealed extensive intramyocardial calcification of the left ventricle. Serial transthoracic echocardiography demonstrated progressive systolic dysfunction, with global longitudinal strain deteriorating from −22% to −9%, and a markedly reduced global work index (GWI 780 mmHg%), indicating impaired intrinsic contractility. Global work efficiency (GWE 96%) remained preserved. Discussion: This is the first reported case of rapidly progressive myocardial calcification associated with CRS, documented using advanced non-invasive imaging modalities such as GLS and myocardial work. These techniques enabled early detection and objective assessment of functional decline in a critically ill patient, in whom conventional diagnostic options were limited.

14 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ALAlejandro Lara-García
Alejandro Lara-García
DTDaniel Tebar
Daniel Tebar
CRCarlos Real
Carlos Real
PSPablo Salinas
Pablo Salinas
GMGonzalo García Martí
Gonzalo García Martí
OIon behalf of the ACI-SEC Pulmonary Embolism Registry Investigators
on behalf of the ACI-SEC Pulmonary Embolism Registry Investigators
Background: Pulmonary embolism (PE) has classically been divided, on the basis of symptom duration, into acute (12 weeks) forms. Subacute PE remains poorly characterised, is frequently underdiagnosed, and is largely absent from randomised trials and dedicated guideline recommendations. Whether the efficacy and safety of catheter-directed therapy (CDT) extend to subacute presentations, in which the thrombus is older, more organised and potentially more adherent, is unknown. We aimed to describe the clinical profile, management and early outcomes of patients with subacute PE selected for CDT within a national interventional registry. Methods: We analysed the National Registry of Catheter-Directed Interventions for the Management of Acute PE (NCT06348459), an investigator-initiated, multicentre registry promoted by the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC). Subacute PE was defined as a symptom duration >14 days and <12 weeks. Baseline characteristics, echocardiographic variables, biomarkers, invasive pulmonary artery pressures, procedural data and early outcomes were described for the subacute group and set alongside the acute presentations treated in the same cohort. All between-group comparisons are descriptive and exploratory and are not intended to characterise subacute PE beyond this selected population. Continuous variables are median [interquartile range]. Results: Among 447 PE cases treated with catheter-directed therapy, 11 (2.5%) met the criteria for subacute PE and 436 (97.5%) for acute PE. Subacute patients presented with progressive dyspnoea (73%) over a median symptom duration of 21 [18–28] days and infrequent syncope (9%); two patients (18%) fulfilled ESC criteria for high-risk PE and three (27%) required vasoactive amines. Subacute patients showed a right ventricular (RV) basal diameter of 50 [48–52] mm (echocardiographic data available in 7 of 11) and an echocardiographic pulmonary artery systolic pressure of 60 [46–60] mmHg, with a high-sensitivity troponin I of 455 [85–767] ng/L and an NT-proBNP of 1433 [256–1970] pg/mL; corresponding values in acute PE were 47 [44–50] mm, 50 [43–60] mmHg, 237 [97–853] ng/L and 2200 [626–5535] pg/mL. None of the between-group differences reached statistical significance. Catheter-directed therapy achieved 100% procedural success in the subacute group, with invasive systolic pulmonary artery pressure falling from 58 [53–60] to 48 [39–51] mmHg and peripheral oxygen saturation improving from 92% [89–95] to 95% [92–98], with no major periprocedural complications, no circulatory support and no in-hospital deaths. Conclusions: Subacute PE was an infrequent but clinically recognisable presentation among patients treated with catheter-directed therapy, accounting for 2.5% of the cohort and characterised by weeks of progressive symptoms before referral and by a substantial right ventricular and pulmonary pressure load at presentation. Mechanical thrombectomy was safe and effective in this subgroup, with favourable early outcomes comparable to those of acute PE. These hypothesis-generating findings support dedicated study of the diagnosis, risk stratification and interventional management of subacute PE.

24 August 2026 in Revista de ecocardiografía práctica y otras técnicas de imagen cardíaca
Verified
Journal Article
Open access
PDF file
ALAlejandro Lara-García
Alejandro Lara-García
CLCarmen Labarta-Bello
Carmen Labarta-Bello
ESElena Refoyo Salicio
Elena Refoyo Salicio
GGGabriela Guzmán-Martínez
Gabriela Guzmán-Martínez
La insuficiencia aórtica crónica es una valvulopatía caracterizada por el reflujo diastólico de sangre desde la aorta hacia el ventrículo izquierdo, lo que produce una sobrecarga volumétrica progresiva y remodelado ventricular. La ecocardiografía constituye la técnica de imagen de primera línea para su diagnóstico y seguimiento; sin embargo, en determinados escenarios clínicos puede presentar limitaciones para la cuantificación precisa de la regurgitación. Revisaremos el papel de la resonancia magnética cardíaca (RMC) en la evaluación de la insuficiencia aórtica crónica, incluyendo los principios de cuantificación de la regurgitación, su utilidad clínica y su rol complementario frente a la ecocardiografía. La RMC permite cuantificar de forma directa el volumen regurgitante y la fracción regurgitante mediante secuencias de contraste de fase, constituyendo actualmente el método de referencia para la cuantificación de la insuficiencia aórtica. Además, proporciona una evaluación precisa y reproducible de los volúmenes ventriculares, la función sistólica y la anatomía de la válvula aórtica y de la aorta torácica. Diversos estudios han demostrado que los parámetros obtenidos mediante RMC, como la fracción regurgitante y los volúmenes ventriculares indexados, presentan valor pronóstico y se asocian con la progresión clínica de la enfermedad. La resonancia magnética cardíaca representa una herramienta clave en la evaluación integral de la insuficiencia aórtica crónica. Su elevada precisión para cuantificar la regurgitación y evaluar el remodelado ventricular la convierten en una técnica fundamental, especialmente en situaciones de discordancia o limitaciones de la ecocardiografía.